Similar to protein‐coding genes, we demonstrated that m6A modification increased the half‐life of LNCAROD in HNSCC cells, suggesting m6A marks of LNCAROD mediated by RNA m6A methyltransferases might account for high expression of LNCAROD in HNSCC. The gene discussed is LNCAROD; the disease is head and neck squamous cell carcinoma.